Sean Sachdev

10PUBLICATIONS

106CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Psychological methodology, design and analysisMolecular targetsNanomedicinePredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 26, 2026

Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205.

|Dec 15, 2025

Pediatric H3 K27-altered diffuse midline gliomas may consist of two clinically relevant subsets based on patient age and molecular genetic profile.

Yufan Yang, Nitin Wadhwani, Yuki Aoi

|Nov 20, 2025

Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Deaglan McHugh, Matthew Dallos, Min Yuen Teo

|Apr 17, 2025

Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment.

Paul W Sperduto, Kathryn E Marqueen, Enoch Chang

|Feb 07, 2025

Clinical outcomes for pleomorphic xanthoastrocytoma patients.

Jared J Sullivan, James P Chandler, Maciej S Lesniak

|Jan 23, 2024

A valuable glioblastoma prognostic marker driven by radiosensitivity.

James Randall, Sean Sachdev

Pageof 2

Frequent Collaborators

Roger Stupp

Priya U Kumthekar

Adam M Sonabend

Derek A Wainwright

Daniel Lin

Fred Saad

Howard Sandler

Christopher P Evans

Katherine S Virgo

James L Wade

Frequent Collaborators

Roger Stupp

Priya U Kumthekar

Adam M Sonabend

Derek A Wainwright